CNA Financial
CNA Financial's revenue rose 5.0% to $15.0 billion in fiscal 2025. Its net margin was 8.5%, up from 6.7% a year earlier. Free cash flow was $2.4 billion, down 2.9%. It paid out $1.1 billion in dividends and buybacks, 45% of free cash flow. The diluted share count fell 0.1%.
Net margin is net income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What CNA Financial does
CNA Financial is a U.S. insurance holding company. Its main business is commercial property and casualty insurance, including surety, which covers a company's promise to finish work or meet an obligation. It also provides warranty, risk management information and claims administration services.
It sells through independent agents, brokers and managing general underwriters to small, medium and large businesses, insurers, associations and professionals. Its property and casualty operations are in three segments: Specialty, Commercial and International. Outside those, it reports Life & Group and Corporate & Other segments.
It operates in the United States, Canada, the United Kingdom and Continental Europe, and it has access to business at Lloyd's of London through Syndicate 382. Loews Corporation owned about 92% of its common stock at the end of 2025. CNA says it competes with many stock and mutual insurers on both price and service.
Its biggest risks, as it describes them
- Insurance reserves proving too low to cover the claims it ultimately has to pay.
- Long-term care policies, where actual experience could differ from its assumptions.
- Large losses from natural and man-made disasters.
- Asbestos and environmental pollution claims that could cause material losses.
- Intense competition and the cyclical nature of property and casualty insurance.
Income statement
From fiscal 2016 to 2025, earnings per share grew 4.4% a year and net income 4.5% a year, with the share count about the same.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 2,526 | 2,307 | 2,510 | 2,560 | 2,745 |
| Debt incl. finance leases | 2,779 | 3,024 | 3,581 | 2,973 | 2,971 |
| Net debt (negative means net cash) | 253 | 717 | 1,071 | 413 | 226 |
| Net debt to EBITDA | 0.2x | 0.7x | 0.6x | 0.3x | 0.1x |
| Debt to equity | 0.2x | 0.3x | 0.4x | 0.3x | 0.3x |
| Interest coverage | 13.9x | 8.3x | 12.9x | 10.1x | 13.0x |
| Current ratio | — | — | — | — | — |
| Quick ratio | — | — | — | — | — |
Cash flow
Projections
Project CNA Financial's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought CNA Financial shares on the open market, and 4 insiders sold $2.4 million, $590,875 of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Daniel Paul FranzettiEVP & CAO | Sold | 22,656 | $53.09 | $1.2 million | Form 4 |
| Aug 4, 2026 | Mark Steven JamesEVP, Chief Risk & Rein Off | Sold | 8,273 | $53.15 | $439,710 | Form 4 |
| Mar 19, 2026 | Jeffrey John NeuenschwanderSVP & General Counsel | Sold | 3,287 | $45.97 | $151,103 | Form 4 |
| Jan 2, 2026 | Dino RobustoExecutive Chairman, Director | Sold plan | 6,250 | $47.62 | $297,625 | Form 4 |
| Dec 1, 2025 | Dino RobustoExecutive Chairman, Director | Sold plan | 6,250 | $46.92 | $293,250 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | 28.5% | 24.6% | 21.1% |
| Altman Z'' | — | — | — |
| Accruals ratio | −1.7% | −2.5% | −1.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | Pass | Pass |
| Current ratio rose | — | — | — |
| Share count didn't rise | Pass | Fail | Pass |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Pass | Pass | Pass |
| F-score | — | — | — |
Compare
Put CNA Financial side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| CNA Financial | FY25 | 5.0% | — | 16.0% | 12.2% | 0.1x | — | |
| W. R. Berkley | FY25 | 7.8% | — | — | — | — | — | Compare |
| Markel Group | FY25 | 4.7% | 20.6% | 16.5% | 15.8% | −0.5x | — | Compare |
| Fidelity National Financial | FY25 | 5.6% | — | — | — | −0.1x | — | Compare |
| Cincinnati Financial | FY25 | 11.4% | — | 24.5% | 17.1% | −0.3x | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 9,366 | 9,542 | 10,134 | 10,767 | 10,808 | 11,908 | 11,879 | 13,299 | 14,270 | 14,989 |
| Revenue growth | 2.9% | 1.9% | 6.2% | 6.2% | 0.4% | 10.2% | −0.2% | 11.9% | 7.3% | 5.0% |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — | — | — |
| Net income | 859 | 899 | 813 | 1,000 | 690 | 1,184 | 682 | 1,205 | 959 | 1,278 |
| Diluted EPS (US$) | 3.17 | 3.30 | 2.98 | 3.67 | 2.53 | 4.34 | 2.51 | 4.43 | 3.52 | 4.69 |
| Diluted shares (millions) | 271 | 272 | 272 | 272 | 272 | 273 | 272 | 272 | 273 | 272 |
| Cash flow | ||||||||||
| Cash from operations | 1,416 | 1,254 | 1,227 | 1,140 | 1,775 | 1,997 | 2,502 | 2,285 | 2,571 | 2,490 |
| Capital expenditure | 146 | 102 | 99 | 26 | 23 | 26 | 52 | 90 | 95 | 86 |
| Free cash flow | 1,270 | 1,152 | 1,128 | 1,114 | 1,752 | 1,971 | 2,450 | 2,195 | 2,476 | 2,404 |
| Dividends paid | 813 | 842 | 896 | 929 | 950 | 621 | 982 | 787 | 1,025 | 1,047 |
| Share buybacks | 0 | 0 | 0 | 23 | 18 | 18 | 39 | 24 | 20 | 34 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 36 | 36 | 32 | 34 | 37 | 32 | 36 | 38 | 42 | 41 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 1,678 | 1,791 | 1,596 | 2,103 | 2,326 | 2,526 | 2,307 | 2,510 | 2,560 | 2,745 |
| Debt incl. finance leases | 2,710 | 2,858 | 2,680 | 2,679 | 2,776 | 2,779 | 3,024 | 3,581 | 2,973 | 2,971 |
| Total assets | 55,233 | 56,567 | 57,152 | 60,612 | 64,026 | 66,639 | 61,000 | 64,711 | 66,492 | 69,443 |
| Total liabilities | 43,264 | 44,323 | 45,935 | 48,397 | 51,319 | 53,830 | 52,452 | 54,818 | 55,979 | 57,822 |
| Shareholders' equity | 11,969 | 12,244 | 11,217 | 12,215 | 12,707 | 11,105 | 8,548 | 9,893 | 10,513 | 11,621 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — | — | — |
| Net margin | 9.2% | 9.4% | 8.0% | 9.3% | 6.4% | 9.9% | 5.7% | 9.1% | 6.7% | 8.5% |
| Free cash flow margin | 13.6% | 12.1% | 11.1% | 10.3% | 16.2% | 16.6% | 20.6% | 16.5% | 17.4% | 16.0% |
| Rule of 40 (growth + FCF margin) | 16.5% | 13.9% | 17.3% | 16.6% | 16.6% | 26.7% | 20.4% | 28.5% | 24.6% | 21.1% |
| Return on capital | 7.8% | 7.7% | 7.3% | 8.8% | 6.1% | 10.4% | 7.5% | 12.9% | 9.7% | 12.2% |
| Return on equity | 7.2% | 7.4% | 6.9% | 8.5% | 5.5% | 9.9% | 6.9% | 13.1% | 9.4% | 11.6% |
| Return on assets | 1.6% | 1.6% | 1.4% | 1.7% | 1.1% | 1.8% | 1.1% | 1.9% | 1.5% | 1.9% |
| Net debt to EBITDA | 0.8x | 0.7x | 0.9x | 0.4x | 0.5x | 0.2x | 0.7x | 0.6x | 0.3x | 0.1x |